Partnering & Outsourcing Editorial

  1. What To Look For In Rare Disease Partnerships, With Origami's Beth Hoffman 3/17/2026

    Origami Therapeutics CEO Beth Hoffman shares how the company took both a measured and a gut-feeling approach to finding the right partner to supports its development of protein degraders for neurodegenerative diseases.

  2. Avoid Clinical Alignment Breakdowns With "Lateral Agility" 3/6/2026

    Internal misalignment can stall the clinical timeline, erode the window of patent protection, and jeopardize funding. Learn why leadership can no longer be and instead must exhibit "lateral agility" across the enterprise.

  3. Outsourcing? When Both Sides Of The Table Are Investor-Backed, Everything Changes 3/6/2026

    The outsourcing relationship is increasingly not sponsor versus provider. It is two investor-backed organizations navigating parallel pressures — with a shared program sitting in the middle.

  4. The Cost Of Transactional Thinking In Clinical Research 2/26/2026

    Denise N. Bronner of Empactful Ventures explores the power dynamics at play in clinical research, picking apart the roles of sponsors, vendors, and sites and advocating for a better way to do business among them.

  5. When AI Meets Accounting: AI Costs And Intangible Asset Treatment For Sponsors And CROs 2/13/2026

    Learn how to account for AI-related costs under evolving U.S. Generally Accepted Accounting Principles (GAAP).

  6. Pharma Procurement Can Make Or Break Startups: Let's Help Mature Our Future Partners To Secure Innovation 2/6/2026

    To secure long-term innovation, Ascendis Pharma's Ivanna Rosendal suggests pharma companies should help startup companies through their growing pains.

  7. How To Lead A Moonshot Collaboration: Lessons From Over A Decade Of Competitors Working Together 2/3/2026

    TransCelerate BioPharma's Andy Lee and Janice Change share the lessons they learned bringing disparate voices together for a united purpose.

  8. What CROs Do Right Isn't Always Obvious To Research Sites 1/26/2026

    CROs are doing many things right. But it's when that right thing is understood — not just executed — that the impact becomes far greater than compliance alone.

  9. Common Issues And Trends In Clinical Research Vendor Qualification 1/21/2026

    Discover the biggest challenges in vendor qualification, including this one misalignment that affected more than half of surveyed respondents.

  10. From Lab To Launch: Navigating The Transition To Commercial Readiness 1/13/2026

    Many clinical-stage companies start thinking about commercialization too late. FTI Consulting experts team up to provide guidance on getting started early.